Abstract:Traditional medicinal plants Mitragyna Speciosa and Plumbago Indica have exhibited several neuroprotective activities against Parkinsons disease (PD) in several research studies. Nevertheless, further elucidation is needed about the molecular mechanism by which these medicinal plants exert their neuroprotective effects and the relationship between their active constituents' structure and activity. Using a polypharmacology approach, the study identified metabolic pathways targeted by active phytochemicals of these medicinal plants. Extensive system biology approaches, including protein-protein interaction network analysis, KEGG pathway analysis, and gene functional enrichment study, pinpointed that AKT1 was the key gene involved in the molecular mechanism actions of the active phytochemicals concerning neuroprotective actions. A robust machine-learning guided bioactivity prediction model-based web application (https://akt1pred.streamlit.app/) against AKT1 was developed by implementing PubChem and Substructure fingerprint molecular signatures. Further validation of the model was done by conducting ROC and applicability domain analysis, with subsequent molecular docking studies to understand the molecular mechanisms of the phytochemicals. The web application predicted that delphinidin and kaempferol were the most active phytochemicals responsible for the neuroprotective effects of the medicinal plants, which was further supported by extensive molecular docking and molecular dynamics simulation study. These findings indicate a correlation between the structure of these compounds and their bioactivity, with some phytochemicals performing comparably or better than known FDA drugs. Results suggest significant potential for natural products in therapeutic applications, urging further in vitro and in vivo investigation and offering a robust foundation for future research into natural product-based small molecule binding and drug discovery in PD.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to elucidate the molecular mechanisms of medicinal plants **Mitragyna Speciosa** and **Plumbago Indica** on Parkinson's disease (PD), especially how the active ingredients in these plants exert neuroprotective effects and the relationship between their structures and activities. ### Main research contents: 1. **Multi - pharmacological approach**: Identify the metabolic pathways targeted by the active ingredients in these medicinal plants through a multi - pharmacological approach. 2. **Systems biology approach**: Using protein - protein interaction network analysis, KEGG pathway analysis and gene function enrichment studies, the crucial role of the AKT1 gene in the neuroprotective effects of these active ingredients was determined. 3. **Machine - learning - assisted QSAR modeling**: A bioactivity prediction model based on machine learning was developed and deployed as a web application ([https://akt1pred.streamlit.app/](https://akt1pred.streamlit.app/)), which is used to predict the inhibitory activity of small molecules against AKT1. 4. **Molecular docking and dynamics simulation**: The prediction results of the model were further verified by molecular docking and molecular dynamics simulation studies, especially the neuroprotective effects of two active ingredients, delphinidin and kaempferol. ### Research background: - Parkinson's disease is a chronic degenerative disease affecting the central nervous system, and its main clinical symptoms include muscle stiffness, tremors, and movement disorders. - Current anti - Parkinson drugs mainly focus on relieving motor and non - motor symptoms, but cannot stop or delay the progression of the disease. - Natural products have a wide range of pharmacological effects and potential value for new drug development. In particular, the traditional medicinal plants **Mitragyna Speciosa** and **Plumbago Indica** have shown certain neuroprotective effects. ### Research methods: - **Network pharmacology analysis**: Screened the active compounds and their targets in the two plants and carried out GO/KEGG analysis. - **Machine - learning model**: Using the data in the ChEMBL database, a random forest (RF) model based on PubChem fingerprints and sub - structure fingerprints was constructed. - **Molecular docking and dynamics simulation**: Verified the prediction results of the model through molecular docking and dynamics simulation. ### Main findings: - **AKT1 gene**: Was identified as the key gene for these active ingredients to exert neuroprotective effects. - **Prediction model**: The developed web application can predict the inhibitory activity of small molecules against AKT1. - **Active ingredients**: Delphinidin and kaempferol were predicted to be the most effective neuroprotective active ingredients and were verified by molecular docking and dynamics simulation. ### Conclusion: This study provides important theoretical basis and technical support for the application of natural products in the treatment of Parkinson's disease, emphasizing the necessity of further in - vitro and in - vivo experiments to explore the small - molecule binding and drug discovery potential of these natural products.

Elucidating the molecular mechanism of phytochemicals against Parkinson's disease through an integrated systems biology and molecular modeling approach

Neuroprotective potential of polydatin in combating Parkinson’s disease through the inhibition of Monoamine Oxidase-B and Catechol-o-Methyl Transferase

Network analysis and molecular modeling studies of pinocembrin a bioactive phytochemical of Dodonaea viscosa against Parkinson's disease

Phytochemicals in Parkinson's Disease: a Pathway to Neuroprotection and Personalized Medicine

Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson's Disease

Molecular Insights into Active Phytochemicals for Diabetes and Inflammation Treatment: A Web App-Based Machine Learning and Network Pharmacology Approach

Insights into dietary phytochemicals targeting Parkinson's disease key genes and pathways: A network pharmacology approach

Uncovering the Pharmacology of Ginkgo Biloba Folium in the Cell-Type-specific Targets of Parkinson's Disease.

Integrating Blood Biomarkers and Marine Brown Algae-Derived Inhibitors in Parkinson's Disease: A Multi-scale Approach from Interactomics to Quantum Mechanics

System biology-based assessment of the molecular mechanism of IMPHY000797 in Parkinson's disease: a network pharmacology and in-silico evaluation

In silico Evaluation of the Feasibility of Magnolia officinalis Electronshuttling Compounds as Parkinson’s Disease Remedy

Unveiling Lobophytum sp. the neuroprotective potential of Parkinson's disease through multifaceted mechanisms, supported by metabolomic analysis and network pharmacology

Natural Products as Novel Neuroprotective Agents; Computational Predictions of the Molecular Targets, ADME Properties, and Safety Profile

Discovery, Synthesis, and Functional Characterization of a Novel Neuroprotective Natural Product from the Fruit of Alpinia Oxyphylla for Use in Parkinson’s Disease Through LC/MS-Based Multivariate Data Analysis-Guided Fractionation

Integrating Network Pharmacology, Transcriptomics to Reveal Neuroprotective of Curcumin Activate PI3K / AKT Pathway in Parkinson's Disease

Molecular Understanding of the Translational Models and the Therapeutic Potential Natural Products of Parkinson's Disease

Moringa oleifera Modulates MPTP-induced Mitochondrial Dysfunction in Parkinson’s Mouse Model: An in silico and in vivo Analysis

In Vivo Dopamine Neuron Imaging-Based Small Molecule Screen Identifies Novel Neuroprotective Compounds and Targets

Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson's disease

Multifunctional Role of Natural Products for the Treatment of Parkinson’s Disease: at a Glance

<i>In Vivo</i> Dopamine Neuron Imaging-Based Small Molecule Screen Identifies Novel Neuroprotective Compounds and Targets